Abiomed (ABMD) News Today → This military-backed stock “owns” AI market (From Porter & Company) (Ad) Free ABMD Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 17, 2024 | finance.yahoo.com‘We think in decades’: J&J’s $30B spending spree may not be overApril 3, 2024 | bizjournals.comFDA issues alert on Abiomed heart pump associated with 49 deathsApril 1, 2024 | msn.comAbiomed Heart Pumps Linked to 49 DeathsMarch 21, 2024 | yahoo.comUS FDA classifies corrections to instructions for Abiomed's blood pumps as most seriousMarch 21, 2024 | reuters.comUS FDA classifies recall of Abiomed's blood pumps as most seriousMarch 19, 2024 | forbes.comWill Johnson & Johnson Stock Rebound To Its Pre-Inflation Shock Highs Of $185?January 16, 2024 | finance.yahoo.comAbiomed Inc's Pipeline Analysis for 2023 Reveals Clinical Advancement in Circulatory Support TechnologyOctober 23, 2023 | finance.yahoo.comAbiomed to Highlight Data Analysis Identifying Complex Clinical Profile of Patients Receiving Impella-Supported HRPCI at TCT SymposiumOctober 14, 2023 | bizjournals.comFDA warns Abiomed over device classificationJune 7, 2023 | msn.comJ&J's Abiomed unit recalls Impella 5.5 heart pumps over safety concernsMay 1, 2023 | uk.finance.yahoo.comAbiomed, Inc. (ABMD) stock price, news, quote & history – Yahoo FinanceMarch 21, 2023 | stocknews.comWant to Retire a Millionaire? 2 Stocks to Buy NowMarch 17, 2023 | stocknews.com3 Stocks That Could Deliver Healthy Returns in 2023March 13, 2023 | stocknews.comThis Big Pharma Stock Is a Clear Buy in 2023March 12, 2023 | uk.finance.yahoo.comAbiomed, Inc. (ABMD) stock historical prices & data – Yahoo FinanceMarch 10, 2023 | stocknews.com3 Powerhouse Stocks to Buy in 2023March 6, 2023 | stocknews.com3 Hot Dividend Stocks to Buy Now and Hold ForeverMarch 4, 2023 | finance.yahoo.comAbiomed, Inc. (ABMD) Stock Historical Prices & Data - Yahoo FinanceMarch 2, 2023 | stocknews.com2 No-Brainer Warren Buffett Stocks to Buy in 2023March 1, 2023 | stocknews.com3 S&P 500 Stocks to Buy If You Like WinningFebruary 28, 2023 | stocknews.com3 Stocks to Help Grow Your Portfolio Over the Next DecadeFebruary 6, 2023 | marketbeat.comAbiomed, Inc. (NASDAQ:ABMD) Shares Acquired by Nisa Investment Advisors LLCNisa Investment Advisors LLC grew its stake in Abiomed, Inc. (NASDAQ:ABMD - Get Rating) by 6.5% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,391 shares of the medical equipment provider's stock after pJanuary 23, 2023 | marketbeat.comIllinois Municipal Retirement Fund Has $4.51 Million Stock Position in Abiomed, Inc. (NASDAQ:ABMD)Illinois Municipal Retirement Fund boosted its stake in shares of Abiomed, Inc. (NASDAQ:ABMD - Get Rating) by 130.9% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 18,362 shares of the medical equipment provider's stock after buying an additional 10,408January 16, 2023 | marketbeat.comGeneva Capital Management LLC Has $21.91 Million Holdings in Abiomed, Inc. (NASDAQ:ABMD)Geneva Capital Management LLC decreased its holdings in Abiomed, Inc. (NASDAQ:ABMD - Get Rating) by 1.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 89,179 shares of the medical equipment provider's stock after sellDecember 26, 2022 | marketbeat.comAbiomed, Inc. (NASDAQ:ABMD) Given Average Recommendation of "Hold" by AnalystsAbiomed, Inc. (NASDAQ:ABMD - Get Rating) has received an average recommendation of "Hold" from the eight ratings firms that are presently covering the stock, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a hold rating and one has given a buy rating to theDecember 22, 2022 | finance.yahoo.com3 Reasons to Retain Abiomed (ABMD) Stock in Your PortfolioDecember 22, 2022 | marketbeat.comTrading was temporarily halted for "ABMD" at 07:12 PM with a stated reason of "News pending."December 21, 2022 | marketbeat.comStock Traders Buy Large Volume of Put Options on Abiomed (NASDAQ:ABMD)Abiomed, Inc. (NASDAQ:ABMD - Get Rating) was the target of some unusual options trading on Wednesday. Stock traders acquired 4,396 put options on the company. This represents an increase of approximately 329% compared to the typical volume of 1,024 put options.December 21, 2022 | finance.yahoo.comFDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clinical TrialDecember 16, 2022 | marketbeat.comAbiomed, Inc. (NASDAQ:ABMD) Sees Large Growth in Short InterestAbiomed, Inc. (NASDAQ:ABMD - Get Rating) saw a large growth in short interest in November. As of November 30th, there was short interest totalling 753,600 shares, a growth of 12.9% from the November 15th total of 667,400 shares. Based on an average daily trading volume, of 912,600 shares, the short-interest ratio is presently 0.8 days. Approximately 1.7% of the shares of the stock are sold short.December 16, 2022 | marketbeat.comAbiomed, Inc. (NASDAQ:ABMD) Sees Large Growth in Short InterestAbiomed, Inc. (NASDAQ:ABMD - Get Rating) was the target of a significant growth in short interest in November. As of November 30th, there was short interest totalling 753,600 shares, a growth of 12.9% from the November 15th total of 667,400 shares. Currently, 1.7% of the company's stock are sold short. Based on an average daily trading volume, of 912,600 shares, the days-to-cover ratio is presently 0.8 days.December 13, 2022 | finance.yahoo.com10 Best Performing Stocks in NovemberDecember 13, 2022 | marketbeat.comCan Pfizer, Johnson & Johnson Continue Outperforming the Index? (ABMD)Large-cap pharmaceuticals Pfizer and Johnson & Johnson are outperforming the broader market in the past year, particularly in the past three months.December 8, 2022 | finance.yahoo.comThis Monster Dividend Stock Isn't Done GrowingDecember 5, 2022 | finance.yahoo.comFirst Patients in the World Treated with Impella RP Flex with SmartAssistDecember 1, 2022 | finance.yahoo.comWhy Is Abiomed (ABMD) Up 1.2% Since Last Earnings Report?December 1, 2022 | marketbeat.comAbiomed, Inc. (NASDAQ:ABMD) Given Average Rating of "Hold" by AnalystsShares of Abiomed, Inc. (NASDAQ:ABMD - Get Rating) have been assigned a consensus rating of "Hold" from the eight analysts that are covering the firm, Marketbeat Ratings reports. Seven investment analysts have rated the stock with a hold rating and one has given a buy rating to the company. The aNovember 28, 2022 | marketbeat.comAbiomed, Inc. (NASDAQ:ABMD) Sees Large Decrease in Short InterestAbiomed, Inc. (NASDAQ:ABMD - Get Rating) was the target of a significant decrease in short interest during the month of November. As of November 15th, there was short interest totalling 667,400 shares, a decrease of 67.9% from the October 31st total of 2,080,000 shares. Based on an average trading volume of 833,800 shares, the short-interest ratio is currently 0.8 days. Currently, 1.5% of the company's shares are sold short.November 24, 2022 | marketbeat.comZacks Research Analysts Decrease Earnings Estimates for Abiomed, Inc. (NASDAQ:ABMD)Abiomed, Inc. (NASDAQ:ABMD - Get Rating) - Equities researchers at Zacks Research reduced their Q3 2023 earnings per share estimates for shares of Abiomed in a note issued to investors on Tuesday, November 22nd. Zacks Research analyst D. Dey now anticipates that the medical equipment provider wilNovember 18, 2022 | marketbeat.comZacks Research Equities Analysts Cut Earnings Estimates for Abiomed, Inc. (NASDAQ:ABMD)Abiomed, Inc. (NASDAQ:ABMD - Get Rating) - Stock analysts at Zacks Research reduced their Q1 2024 earnings estimates for Abiomed in a research report issued on Tuesday, November 15th. Zacks Research analyst D. Dey now forecasts that the medical equipment provider will post earnings of $1.21 per sNovember 16, 2022 | marketbeat.comAbiomed, Inc. (NASDAQ:ABMD) Short Interest Up 5.6% in OctoberAbiomed, Inc. (NASDAQ:ABMD - Get Rating) was the target of a large growth in short interest in October. As of October 31st, there was short interest totalling 2,080,000 shares, a growth of 5.6% from the October 15th total of 1,970,000 shares. Currently, 4.7% of the shares of the company are sold short. Based on an average daily trading volume, of 547,300 shares, the short-interest ratio is presently 3.8 days.November 13, 2022 | marketbeat.comS&P 500 Component DexCom Set For Further Price, Earnings Growth (ABMD)Glucose monitor maker DexCom surged 19% after its Q3 report, and shares are holding those gains. Wall Street sees more growth ahead in 2023.November 10, 2022 | finance.yahoo.comJohnson & Johnson Could Level Up With Its $16.8 Billion Purchase of AbiomedNovember 8, 2022 | marketbeat.comInsider Selling: Abiomed, Inc. (NASDAQ:ABMD) VP Sells 2,000 Shares of StockAbiomed, Inc. (NASDAQ:ABMD - Get Rating) VP Marc A. Began sold 2,000 shares of the company's stock in a transaction dated Friday, November 4th. The stock was sold at an average price of $373.71, for a total transaction of $747,420.00. Following the completion of the transaction, the vice president now owns 13,785 shares in the company, valued at $5,151,592.35. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.November 6, 2022 | marketbeat.comAbiomed, Inc. (NASDAQ:ABMD) Receives Average Recommendation of "Hold" from AnalystsAbiomed, Inc. (NASDAQ:ABMD - Get Rating) has earned a consensus recommendation of "Hold" from the eight research firms that are currently covering the stock, Marketbeat.com reports. Seven analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average 1November 5, 2022 | finance.yahoo.comJohnson & Johnson's Big Purchase, Amazon's New Moves, and MoreNovember 2, 2022 | marketbeat.comAbiomed Sees Unusually High Options Volume (NASDAQ:ABMD)Abiomed, Inc. (NASDAQ:ABMD - Get Rating) was the recipient of some unusual options trading activity on Wednesday. Stock traders acquired 2,874 put options on the company. This is an increase of 1,155% compared to the average daily volume of 229 put options.November 2, 2022 | marketbeat.comAbiomed (NASDAQ:ABMD) Upgraded to Equal Weight by Morgan StanleyMorgan Stanley raised shares of Abiomed from an "underweight" rating to an "equal weight" rating in a report on Wednesday.November 1, 2022 | wsj.comJ&J Agrees to Buy Heart-Device Maker Abiomed for $16.6 BillionNovember 1, 2022 | finance.yahoo.comAbiomed (ABMD) Q2 Earnings Top Estimates, Margins Down Get Abiomed News Delivered to You Automatically Sign up to receive the latest news and ratings for ABMD and its competitors with MarketBeat's FREE daily newsletter. Email Address SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. ABMD Media Mentions By Week ABMD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABMD News Sentiment▼0.440.78▲Average Medical News Sentiment ABMD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABMD Articles This Week▼00▲ABMD Articles Average Week Get Abiomed News Delivered to You Automatically Sign up to receive the latest news and ratings for ABMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: iRhythm Technologies News Today NovoCure News Today Nevro News Today Becton, Dickinson and Company News Today Edwards Lifesciences News Today DexCom News Today IDEXX Laboratories News Today ResMed News Today STERIS News Today Baxter International News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ABMD) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abiomed, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
